Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02554708
Other study ID # PTW/PV201505-21
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 2015
Est. completion date October 2019

Study information

Verified date September 2022
Source Phenox GmbH
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To assess safety and efficacy of pCONus for the treatment of wide neck bifurcation aneurysms.


Description:

Title: pCONus Treatment of Wide Neck Intracranial Aneurysms Acronym: pToWin Device: pCONus Bifurcation Aneurysm Implant Study design: Prospective, multicenter, single-arm clinical investigation Purpose: To assess safety and efficacy of pCONus for the treatment of wide neck bifurcation aneurysms Duration of the study: 48 months Sample size: 100 evaluable patients Number of sites: > 20 Follow-up intervals: Two independent follow-ups (after 3-6 and 7-12 months) according to site specific standard


Recruitment information / eligibility

Status Completed
Enrollment 116
Est. completion date October 2019
Est. primary completion date October 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: 1. Aneurysm status: - Unruptured aneurysm or - Ruptured aneurysm with a Hunt and Hess grade of I - III. 2. Age =18 and = 80 years. 3. The patient or legal representative provides written informed consent. 4. The patient shows general compliance to follow the medical regimen and to attend follow-up examinations. 5. The target aneurysm is located at one of the following cerebral vessel bifurcations: ICA terminus, AcomA, MCA or BA. 6. Bifurcation wide neck aneurysm. 7. The dome height should allow for safe deployment of the device crown. The fundus of the aneurysm should offer enough space for the crown of the pCONus to deploy. Exclusion Criteria: 1. Vessel tortuosity precluding safe access and device deployment. 2. Stenosis within the vascular access or target vessel = 50 %. 3. The target aneurysm has been previously treated with a stent or an intraaneurysmal implant beside coils. 4. The treatment plan for the target aneurysm includes the use of additional intra- and/or extraaneurysmal temporary or permanent implants other than coils. 5. More than one intracerebral aneurysm requires the treatment within the following 6 months. 6. Imaging evidence of an arteriovenous cerebrovascular malformation or a dural fistula. 7. Any physical, medical or psychiatric condition of the patient interfering with the adherence of the requirements and follow-up regimen of the study. 8. Any neurological disorder with progressive neurological symptoms, except attributable to a compressive effect of the target aneurysm. 9. Current involvement in another study or trial. 10. Women of child bearing potential or breast-feeding who cannot provide a negative pregnancy test. 11. Known allergy to the components of device, study medication or contrast media that cannot be controlled medically. 12. A medical condition interfering with a dual antiplatelet treatment. 13. Known coagulopathy. 14. Intracranial hemorrhage in the past 30 days apart from the target aneurysm. 15. Ischemic stroke in the past 30 days. 16. Myocardial infarction in the past 30 days. 17. Major surgery in the past 30 days. 18. Evidence of active infection at time of treatment. 19. Co -morbidities or conditions with a life expectancy less than 12 months. 20. Additional Exclusion criteria for ruptured aneurysm at the acute phase: 1. The patient is clinically severely affected (Hunt and Hess grade IV and V). 2. Severe vasospasm is proven during angiography. 3. Proven parenchymal hemorrhage by CT or MRI. 4. Proven subdural hematoma by CT or MRI.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
implantation of the pCONus Bifurcation Aneurysm Implant
The device will be introduced through a regular microcatheter. After deployment of the device with the crown positioned in the aneurysm neck the aneurysm will be entered with a microcatheter to perform endovascular coil occlusion. After completion of the coiling procedure the pCONus device will be electrolytically detached from the insertion wire and only the crown and the shaft will remain as a permanent implant.

Locations

Country Name City State
Argentina Clínica La Sagrada Familia Department of Neuroscience (P.L.), Equipo de Neurocirugía Endovascular y Radiología Intervencionista Buenos Aires Ciudad Autónoma De Buenos Aires
Austria LKH-Univ. Klinikum Graz Universitätsklinik für Radiologie Graz
France Hôpital Pierre Wertheimer (HCL Groupement Hospitalier Est) Bron cedex
Germany KRH Klinikum Nordstadt Hannover Niedersachsen
Germany Universitätsklinikum Heidelberg Heidelberg
Germany Gemeinschaftsklinikum Mittelrhein gGmbH Koblenz
Germany Klinikum Osnabrück Osnabrück
Germany Knappschaftskrankenhaus Recklinghausen Recklinghausen
Germany Klinikum Stuttgart Katharinenhospital Stuttgart
Italy A.S.L. Napoli 1 Centro - P.O. San Giovanni Bosco Napoli

Sponsors (1)

Lead Sponsor Collaborator
Phenox GmbH

Countries where clinical trial is conducted

Argentina,  Austria,  France,  Germany,  Italy, 

References & Publications (1)

Aguilar Pérez M, Henkes H, Kurre W, Bleise C, Lylyk PN, Lundquist J, Turjman F, Alhazmi H, Loehr C, Felber S, Deutschmann H, Lowens S, Delehaye L, Möhlenbruch M, Hattingen J, Lylyk P. Results of the pToWin Study: Using the pCONUS Device for the Treatment of Wide-Neck Intracranial Aneurysms. J Clin Med. 2022 Feb 8;11(3). pii: 884. doi: 10.3390/jcm11030884. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Effectiveness Aneurysm occlusion (complete or neck remnant) Change from post-procedure to 3-6 and to 7-12 months
Primary Safety Major stroke (ischemic or hemorrhagic) or neurological death related to the treatment of the target aneurysm within 12 months
Secondary Effectiveness The "Effectiveness endpoint" is assessed throughout the intervention and is assessed as "number/amount of" for each following point:
To place pCONus in the desired location
Correct opening of the device (crown and shaft)
To perform aneurysm occlusion without obliteration of side branches and
To detach the device at the end of the procedure
at the time of the procedure
Secondary Safety Intra-Procedural Complications The "Safety Intra-Procedural Complications" endpoint is assessed throughout the intervention and is assessed as "number/amount of" for each following point:
Vessel perforation
Target aneurysm perforation with microcatheter or guidewire
Target aneurysm perforation with pCONus
Target aneurysm perforation with coils
Thromboembolism
Dissection of any access vessel
at the time of the procedure
Secondary Safety Post-Procedural Complications The "Safety Post-Procedural Complications" endpoint is assessed throughout the intervention and is assessed as "number/amount of" for each following point:
Frequency of new parenchymal hemorrhage during the follow-up period
Frequency of new subarachnoid hemorrhage during the follow-up period
Frequency of new ischemic stroke on follow-up imaging
Rupture of the target aneurysm during the 12 months follow-up period
Rate of in-stent-stenosis
Rate of in-stent-thrombosis
Change 1day post procedure up to 12months
See also
  Status Clinical Trial Phase
Recruiting NCT04870047 - Coating to Optimize Aneurysm Treatment In The New Flow Diverter Generation N/A
Recruiting NCT05968053 - Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
Not yet recruiting NCT05665309 - Interest of Pre-operative Use of 3D Printing for Endovascular Treatment of Unruptured Intracranial Aneurysms With Intrasaccular Flow Disruptor N/A
Completed NCT02783339 - Neuroform Atlas Stent for Intracranial Aneurysm Treatment
Withdrawn NCT01194388 - Axium Coil in Completing Endovascular Aneurysm Surgery Study
Completed NCT00071565 - Familial Intracranial Aneurysm Study II N/A
Recruiting NCT05409989 - MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study N/A
Completed NCT03680742 - Contour Neurovascular System - European Pre-Market Unruptured Aneurysm N/A
Completed NCT04872842 - Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on 100 Regional Medical Centers in China and Population Follow-up Study
Terminated NCT02532517 - Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device N/A
Completed NCT03663257 - Study to Evaluate Cerebral AneurysmFlow Results in Occlusion
Recruiting NCT06189950 - Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE N/A
Recruiting NCT05608122 - Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on Regional Medical Centers in China and Population Follow-up Study (Phase Ⅱ)
Recruiting NCT03661463 - Unruptured Intracranial Aneurysm Aspirin Trial (UIAAT). Phase 2
Completed NCT02609867 - A Feasibility Study to Evaluate the Safety and Effectiveness of Implantation of Flowise Cerebral Flow Diverter (Flowise) N/A
Active, not recruiting NCT02292017 - Prospective Packing Density With Target Coils I N/A
Active, not recruiting NCT01872741 - Minipterional Versus Pterional Craniotomy N/A
Completed NCT00993057 - Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia Early Phase 1
Completed NCT00777907 - Complete Occlusion of Coilable Aneurysms Phase 3
Completed NCT00777088 - Pipeline for Uncoilable or Failed Aneurysms N/A